Modulation of the rat suprachiasmatic circadian clock by melatonin in vitro.
The pineal hormone melatonin regulates daily and seasonal rhythms, at least in part through an action on the mammalian biological clock in the suprachiasmatic nuclei (SCN). Melatonin was tested in vitro (10(-15)-10(-6) M; ZT9.5-10.5) for its effect on the circadian peak in neuronal firing rate in the rat SCN slice. It produced a concentration-related phase advance (maximum advance = 3 +/- 0.3 h at 10(-9) M, n = 3; minimum effective concentration = 10(-13) M; EC50 = 1.2 x 10(-12) M). The melatonin receptor antagonist luzindole (10(-5) M) blocked the phase-advance produced by melatonin (10(-9) M), whilst having no effect on its own. These data show that the effect of melatonin on the SCN clock, measured via the circadian rhythm of neuronal firing rate in the nuclei, is consistent with a concentration-dependent action via a high affinity melatonin receptor.
Department of Pharmacology, Glaxo Research and Development Ltd., Ware, Hertfordshire, UK.
S J
SJ
Starkey
M P
MP
Walker
I J
IJ
Beresford
R M
RM
Hagan
D000200:Action Potentials / Q000187:drug effects / Q000502:physiology; D000818:Animals; D002940:Circadian Rhythm / Q000502:physiology*; D066298:In Vitro Techniques; D008297:Male; D008550:Melatonin / Q000037:antagonists & inhibitors / Q000502:physiology*; D009474:Neurons / Q000187:drug effects / Q000502:physiology*; D051381:Rats; D013493:Suprachiasmatic Nucleus / Q000166:cytology / Q000187:drug effects / Q000502:physiology*; D014363:Tryptamines / Q000494:pharmacology
D014363:Tryptamines; C057154:luzindole; D008550:Melatonin